CCNA2 and breast carcinoma: Specifically, CCNA2 overexpression is associated with poor distant metastasis survival in ER+ breast cancer cohorts GSE47561 (Fig. 1A, P = 5.057e−11) and Van dataset (Fig. S1A, and 8.093e−05).